About Us
What motivates us?
Our technology
Clinical Development
Investors
Investor Relations Home
Corporate Governance
Press Releases
Events and Presentations
Stock Information
Interactive Chart
SEC Filings
FAQs
Contact Us
Email Alerts
Twitter
LinkedIn
Careers
Press Releases
Home
Investors
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Email Alerts
Year
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Feb 7, 2022
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe
Photos
1
Jan 5, 2022
Check-Cap Issues Letter to Shareholders
Photos
1
Dec 23, 2021
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification
Photos
1
Nov 22, 2021
Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®
Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy
Photos
1
Nov 3, 2021
Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update
Photos
1
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
26
»
Menu
